Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRPV1 is a nonselective cation channel and a member of the transient receptor potential (TRP) channel family, specifically the vanilloid subfamily. It is primarily involved in the detection of noxious heat (>43°C), acidic conditions (low pH), capsaicin, and other stimuli. Activation of TRPV1 leads to pain sensation, inflammation, and other physiological responses. It is a therapeutic target for chronic pain and other diseases.
Activation leads to opening of the channel pore, allowing influx of cations (Ca2+, Na+, Mg2+), resulting in depolarization of sensory neurons and transmission of pain signals.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential vanilloid subfamily 1 (TRPV1).